OnDemand WTP Pricing Research

Maryland, Massachusetts statehouses press drug-pricing bills as feds founder | FiercePharma

As drug-pricing proposals proliferate at the federal level, states are taking their own steps to rein in sticker prices. That fight hasn’t been easy, what with the pharma industry’s lobbying power. But it’s not impossible, either.

Consider the basket of bills under consideration in Massachusetts. The state legislature’s Joint Committee on Health Care Financing heard testimony on the skyrocketing cost of drugs as it reviewed 21 bills targeting drug pricing and transparency.

One of those bills—HB 1133/SB 706—would require drug manufacturers to report pricing information, including development, research and marketing costs. They’d also have to disclose the factors they consider when raising prices. And perhaps most worrisome for drugmakers, the bill would allow the state’s Health Policy Commission to cap the price of certain drugs based on information the companies report.

Read complete article here:

Maryland, Massachusetts statehouses press drug-pricing bills as feds founder | FiercePharma.